InvestorsHub Logo
Followers 39
Posts 1575
Boards Moderated 0
Alias Born 02/26/2013

Re: None

Sunday, 03/03/2013 6:59:43 PM

Sunday, March 03, 2013 6:59:43 PM

Post# of 158400
I thought the new stem cell play this week was ENTB? I got this earlier. Got to get er done on our own merit. BMSN$$$$$$$


YFRM ~ Our New Stem Cell Biotech pick with big upside (trading at only .0869 cents right now).
YFRM has just bounced off its 50 day moving average and closed above it. We are initiating strong coverage on YFRM right here/right now and feel this wallstreet gem of a play has bottomed and is ready for some great upside potential.
YFRM ~ Is a Hot Stem Cell play we feel is trading very low. We feel this new pick can run high and has big potential. YFRM looks to be a super Wallstreet gem for trading now that it has bottomed and has been way oversold on the charts. This coupled with the recent big news tells us there is Great Short term potential here Members.

YFRM ~ The chart is oversold and it just formed a nice bottom Thursday and Friday, is reversing on the charts, closed above the 50 day moving average and is trading dirt cheap compared to its recent highs at .33 cents. You may want to make sure you're Liquid and Ready this weekend for Monday's trading session.

Dear Valued Members, Our last 3 Biotech plays have broken records: Those 3 plays being AMBS from .005 to .19 cents and BMSN from .001 to .006 cents and ALQA from .049 to .104cents.

YFRM is our New and Next Big Biotech Stem cell play.
This is one you are NOT going to want to miss so get ready today so you can take advantage of YFRM for Monday's Trading session as there is already huge anticipation for YFRM this coming week. YFRM has been releasing some pretty big news in the market with ISCI and we feel this is one has great short term trading potential.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.